KBL MERGER CORP. IV Contracts & Agreements

Offer Letter between 180 Life Science Corp. and Jay Goodman (director) dated October 25, 2024 and effective October 24, 2024 (Filed With SEC on October 29, 2024)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on October 16, 2024)

Form of Warrant Inducement Agreement, by and between the Company and Holder (Filed With SEC on October 16, 2024)

Financial Advisory Agreement, dated as of October 16, 2024, between A.G.P./Alliance Global Partners and the Company (Filed With SEC on October 16, 2024)

Asset Purchase Agreement dated September 29, 2024, by and among Elray Resources, Inc., as seller and 180 Life Sciences Corp., as purchaser (Filed With SEC on October 3, 2024)

Common Stock Purchase Warrant to purchase 3,000,000 shares of common stock dated September 30, 2024, granted by 180 Life Sciences Corp. to Elray Resources, Inc (Filed With SEC on October 3, 2024)

Separation and Release Agreement dated September 5, 2024 and First Amendment to Separation and Release Agreement dated September 5, 2024, by and between Cannbiorex Pharma Ltd.,... (Filed With SEC on September 9, 2024)

Indemnity Agreement dated September 3, 2024 and effective September 5, 2024, between 180 Life Sciences Corp. and Sir Marc Feldmann (Filed With SEC on September 9, 2024)

Separation and Release Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. James N. Woody (Filed With SEC on May 9, 2024)

Separation and Release Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Jonathan Rothbard (Filed With SEC on May 9, 2024)

Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Jonathan Rothbard (Filed With SEC on May 9, 2024)

Fourth Amendment to Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Lawrence Steinman (Filed With SEC on May 9, 2024)

Executive Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. , Blair Jordan and Blair Jordan Strategy and Finance Consulting Inc (Filed With SEC on May 9, 2024)

Form of 180 Life Sciences Corp. Indemnity Agreement (Filed With SEC on May 9, 2024)

Offer Letter between 180 Life Science Corp. and Omar Jimenez (director) dated March 4, 2024 and effective March 7, 2024 (Filed With SEC on March 11, 2024)

Offer Letter between 180 Life Science Corp. and Ryan L. Smith (director) dated March 5, 2024 and effective March 7, 2024 (Filed With SEC on March 11, 2024)

Offer Letter between 180 Life Science Corp. and Blair Jordan (director) dated February 24, 2024 and effective February 28, 2024 (Filed With SEC on February 29, 2024)

Second Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on February 16, 2024)

Second Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on February 16, 2024)

Fourth Amendment to Employment Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on January 17, 2024)

Fourth Amendment to Employment Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on January 17, 2024)

Third Amendment to Consulting Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and Lawrence Steinman, M.D (Filed With SEC on January 17, 2024)

Second Amendment to Consulting Agreement dated January 10, 2024 and effective as of January 1, 2024, between Cannbiorex Pharma Ltd. and Sir Marc Feldmann (Filed With SEC on January 17, 2024)

Form of Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants (Filed With SEC on November 29, 2023)

Warrant Amendment Agreement, dated November 28, 2023, by and between the Company and the Purchaser (Filed With SEC on November 29, 2023)

Amendment No.1 to the Securities Purchase Agreement, dated November 28, 2023, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on November 29, 2023)

180 Life Sciences Corp. Policy for the Recovery of Erroneously Awarded Incentive-Based Compensation (Filed With SEC on November 9, 2023)

Termination Letter (Oxford License) September 22, 2023 (Filed With SEC on September 28, 2023)

Form of Stock Option Agreement (First Amended and Restated 2022 Omnibus Incentive Plan) (Filed With SEC on September 7, 2023)

Placement Agency Agreement, dated August 9, 2023, by and between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners (Filed With SEC on August 15, 2023)

Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants, dated August 14, 2023, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on August 15, 2023)

Warrant Amendment Agreement, dated August 9, 2023, by and between the Company and Armistice Capital Master Fund Ltd (Filed With SEC on August 15, 2023)

Securities Purchase Agreement dated August 9, 2023, by and between 180 Life Sciences Corp. and the Institutional Investor (Filed With SEC on August 15, 2023)

Form of Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants (Filed With SEC on July 25, 2023)

First Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on July 10, 2023)

First Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on July 10, 2023)

Form of Placement Agent Agreement (Filed With SEC on June 16, 2023)

Form of Pre-Funded Warrant (Filed With SEC on June 16, 2023)

Form of Common Warrant (Filed With SEC on June 16, 2023)

Form of Securities Purchase Agreement (Filed With SEC on June 16, 2023)

Form of Lock-Up Agreement (Filed With SEC on June 16, 2023)

Amendment No. 1 to Common Stock Purchase Warrant between 180 Life Sciences Corp. and the warrant holder, dated April 5, 2023 (Filed With SEC on May 15, 2023)

Amended and Corrected Third Amendment to Employment Agreement dated May 9, 2023, between 180 Life Sciences Corp. and Ozan Pamir (Filed With SEC on May 15, 2023)

Amendment No. 1 to the Warrants, dated April 5, 2023, by and between 180 Life Sciences Corp. and the Selling Stockholder (Filed With SEC on May 5, 2023)

Warrant Agent Agreement for the July 2022 Common Warrants, dated July 29, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on May 5, 2023)

Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on April 28, 2023)

Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and Ozan Pamir (Filed With SEC on April 28, 2023)

Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on April 28, 2023)

Placement Agent Agreement, dated April 5, 2023, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners (Filed With SEC on April 10, 2023)

Form of Pre-Funded Warrant (Filed With SEC on April 10, 2023)

Form of Common Warrant (Filed With SEC on April 10, 2023)

Securities Purchase Agreement, dated April 5, 2023, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on April 10, 2023)

Warrant Agent Agreement for Pre-Funded Warrants, dated April 10, 2023 by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on April 10, 2023)

Warrant Agent Agreement for Common Warrants, dated April 10, 2023 by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on April 10, 2023)

Form of Lock-Up Agreement (Filed With SEC on April 10, 2023)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 31, 2023)

First Amendment to Separation and Release Agreement, dated March 29, 2023, by and between 180 Life Sciences Corp. and Quan Vu (Filed With SEC on March 31, 2023)

Separation and Release Agreement, dated January 18, 2023, by and between 180 Life Sciences Corp. and Quan Vu (Filed With SEC on January 20, 2023)

Amendment to the Warrant Agent Agreement, dated January 13, 2023, by and between 180 Life Sciences Corp. and the Warrant Agent (Filed With SEC on January 18, 2023)

Warrant Amendment, dated January 12, 2023, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on January 12, 2023)

Third Amendment to Consulting Agreement dated December 28, 2022, between 180 Life Sciences Corp., Cannbiorex Pharma Ltd. and Prof. Jagdeep Nanchahal (Filed With SEC on December 29, 2022)

Placement Agent Agreement, dated December 20, 2022, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners (Filed With SEC on December 22, 2022)

Form of Pre-Funded Warrant (Filed With SEC on December 22, 2022)

Form of Common Warrant (Filed With SEC on December 22, 2022)

Securities Purchase Agreement, dated December 20, 2022, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on December 22, 2022)

Warrant Agent Agreement for the Pre-Funded Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on December 22, 2022)

Warrant Agent Agreement for the Common Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on December 22, 2022)

Form of Lock-Up Agreement (Filed With SEC on December 22, 2022)

Placement Agent Agreement dated July 17, 2022, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners (Filed With SEC on July 19, 2022)

Form of Pre-Funded Warrant (Filed With SEC on July 19, 2022)

Form of Common Warrant (Filed With SEC on July 19, 2022)

Securities Purchase Agreement dated July 17, 2022, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on July 19, 2022)

Form of Lock-Up Agreement (Filed With SEC on July 19, 2022)

180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on June 14, 2022)

Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on May 27, 2022)

Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on May 27, 2022)

Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on May 27, 2022)

Second Amendment to Consulting Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Lawrence Steinman, M.D (Filed With SEC on May 27, 2022)

First Amendment to Amended and Restated Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on April 28, 2022)

First Amendment to Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on April 28, 2022)

First Amendment to Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on April 28, 2022)

First Amendment to Employment Agreement dated April 27, 2022, between Cannbiorex Pharma Ltd. and Sir Marc Feldmann, Ph.D (Filed With SEC on April 28, 2022)

First Amendment to Consulting Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Lawrence Steinman, M.D (Filed With SEC on April 28, 2022)

Second Amendment to Consulting Agreement dated April 27, 2022, between Cannbiorex Pharma Ltd. and Prof. Jagdeep Nanchahal (Filed With SEC on April 28, 2022)

Consulting Agreement dated November 17, 2021, by and between 180 Life Science Corp. and Lawrence Steinman, M.D (Filed With SEC on November 18, 2021)

Employment Agreement dated October 29, 2021, by and between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on November 2, 2021)

Debt Conversion Agreement dated September 30, 2021, by and between 180 Life Sciences Corp. and Dr. Lawrence Steinman and Sir Marc Feldmann (Filed With SEC on October 5, 2021)

Settlement and Mutual Release Agreement dated September 17, 2021, by and between 180 Life Sciences Corp. and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C (Filed With SEC on September 20, 2021)

Form of Purchaser Warrant (August 2021 Offering) (Filed With SEC on August 24, 2021)

Securities Purchase Agreement dated as of August 19, 2021 by and between 180 Life Sciences Corp. and the purchasers identified on the signature pages thereto (Filed With SEC on August 24, 2021)

Engagement Letter dated August 17, 2021 between 180 Life Sciences Corp. and Maxim Group LLC (Filed With SEC on August 24, 2021)

Registration Rights Agreement dated as of August 23, 2021 by and between 180 Life Sciences Corp. and the purchasers signatory thereto (Filed With SEC on August 24, 2021)

Form of Lock-Up Agreement (August 2021 Offering) (Filed With SEC on August 24, 2021)

Form of Stock Option Agreement (Independent Directors August 2021 Grants) (Filed With SEC on August 16, 2021)

Common Stock Purchase Warrant dated July 31, 2021, to purchase 25,000 shares of common stock of 180 Life Sciences Corp., granted to Alpha Capital Anstalt (Filed With SEC on August 2, 2021)

Mutual Release and Settlement Agreement dated July 31, 2021, issued by 180 Life Sciences Corp. to Alpha Capital Anstalt (Filed With SEC on August 2, 2021)

Sir Marc Feldmann Confirmation of Rescission of Note Amendments effective February 25, 2021 (Filed With SEC on July 19, 2021)

Dr. Lawrence Steinman Confirmation of Rescission of Note Amendments effective February 25, 2021 (Filed With SEC on July 19, 2021)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on July 9, 2021)

Form of August 21, 2019 Employment Agreement between KBL Merger Corp. IV and Jonathan Rothbard (Filed With SEC on July 9, 2021)

Form of Director Nominee Offer Letter (May 2021) (Filed With SEC on May 27, 2021)

Second Amendment to Employment Agreement dated May 27, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp., Katexco Pharmaceuticals Corp. and Ozan Pamir (Filed With SEC on May 27, 2021)

Settlement and Mutual Release Agreement dated May 4, 2021, by and between 180 Life Sciences Corp. and EarlyBirdCapital, Inc (Filed With SEC on May 7, 2021)

First Amendment to Consultancy Agreement dated March 31, 2021, by and between 180 Life Sciences Corp. and Prof Jagdeep Nanchahal (Filed With SEC on April 2, 2021)

Consultancy Agreement dated February 22, 2021, by and between 180 Life Sciences Corp. and Prof Jagdeep Nanchahal (Filed With SEC on March 3, 2021)

Amended and Restated Employment Agreement dated February 25, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp. and James N. Woody (Filed With SEC on March 3, 2021)

James N. Woody - Stock Option Agreement effective February 26, 2021 (1,400,000 shares) (Filed With SEC on March 3, 2021)

Employment Agreement dated February 24, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp. and Ozan Pamir and Amendment and Correction Thereto dated... (Filed With SEC on March 3, 2021)

Ozan Pamir - Stock Option Agreement effective February 26, 2021 (180,000 shares) (Filed With SEC on March 3, 2021)

Form of Warrant (Filed With SEC on February 24, 2021)

Securities Purchase Agreement dated as of February 19, 2021 by and between 180 Life Sciences Corp. and the purchasers identified on the signature pages thereto (Filed With SEC on February 24, 2021)

Engagement Letter dated January 26, 2021 between 180 Life Sciences Corp. and Maxim Group LLC (Filed With SEC on February 24, 2021)

Amendment to Engagement Letter between 180 Life Sciences Corp. and Maxim Group LLC dated February 18, 2021 (Filed With SEC on February 24, 2021)

Registration Rights Agreement dated as of February 23, 2021 by and between 180 Life Sciences Corp. and the purchasers signatory thereto (Filed With SEC on February 24, 2021)

Form of Lock-Up Agreement (Filed With SEC on February 24, 2021)

Amendment Agreement dated November 25, 2020 (Filed With SEC on November 27, 2020)

Form of Lock-Up Agreement (Filed With SEC on November 12, 2020)

Escrow Agreement dated November 6, 2020 by and between the registrant, Continental Stock Transfer & Trust Company, and Lawrence Pemble (Filed With SEC on November 12, 2020)

2020 Omnibus Incentive Plan (Filed With SEC on November 12, 2020)

Employment Agreement, dated July 1, 2020 by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D (Filed With SEC on November 12, 2020)

First Amendment to Employment Agreement by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D (Filed With SEC on November 12, 2020)

Amended and Restated Promissory Note, dated September2020, issued to KBL IV Sponsor LLC (Filed With SEC on October 19, 2020)

Convertible Promissory Note, dated September2020, issued to KBL IV Sponsor LLC (Filed With SEC on October 19, 2020)

Form of 10% Senior Secured Convertible Promissory Note (Filed With SEC on September 14, 2020)

Securities Purchase Agreement, dated September 8, 2020, by and among the Company and the purchasers signatory thereto (Filed With SEC on September 14, 2020)

Registration Rights Agreement, dated September 8, 2020, by and among the Company and the parties signatory thereto (Filed With SEC on September 14, 2020)

Amendment No. 2 to Business Combination Agreement, dated as of August 7, 2020, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder... (Filed With SEC on August 13, 2020)

Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock of the Company (Filed With SEC on July 2, 2020)

Form of 10% Senior Secured Convertible Promissory Note (Filed With SEC on July 2, 2020)

Securities Purchase Agreement, dated June 12, 2020, by and among the Company and the purchasers signatory thereto (Filed With SEC on July 2, 2020)

Registration Rights Agreement, dated June 12, 2020, by and among the Company and the parties signatory thereto (Filed With SEC on July 2, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 7, 2020)

Amendment No. 1 to Business Combination Agreement, dated as of January 29, 2020, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder... (Filed With SEC on February 3, 2020)

Promissory Note, dated March 15, 2019 issued to KBL IV Sponsor LLC (Filed With SEC on November 12, 2019)

Promissory Note, dated August 21, 2019 issued to CannBioRx Life Sciences Corp (Filed With SEC on November 12, 2019)

Promissory Note, dated August 28, 2019 issued to CannBioRx Life Sciences Corp (Filed With SEC on November 12, 2019)

Promissory Note, dated September 30, 2019 issued to CannBioRx Life Sciences Corp (Filed With SEC on November 12, 2019)

Form of Support Agreement, by and between KBL and certain stockholders of the Company (Filed With SEC on July 26, 2019)

Form of Lock-Up Agreement, by and between KBL and certain stockholders of the Company (Filed With SEC on July 26, 2019)

Form of Tyche Backstop Agreement (Filed With SEC on July 26, 2019)

Employment Agreement, dated as of July 23, 2019, by and between KBL and Marlene Krauss (Filed With SEC on July 26, 2019)

Employment Agreement, dated as of July 23, 2019, by and between KBL and George Hornig (Filed With SEC on July 26, 2019)

Business Combination Agreement, dated as of July 25, 2019, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder Representative (Filed With SEC on July 26, 2019)

Underwriting Agreement between the Company and the representatives of the several underwriters set forth therein (Filed With SEC on June 7, 2017)

Warrant Agreement, dated June 1, 2017, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on June 7, 2017)

Investment Management Trust Account Agreement, dated June 1, 2017, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on June 7, 2017)

Rights Agreement, dated June 1, 2017, between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on June 7, 2017)

Registration Rights Agreement among the Company and certain securityholders (Filed With SEC on June 7, 2017)

Letter Agreement by and between the Company and its officers and directors and certain securityholders (Filed With SEC on June 7, 2017)

Third Amended and Restated Unit Subscription Agreement, dated June 1, 2017 between the Company and KBL IV Sponsor LLC (Filed With SEC on June 7, 2017)

Third Amended and Restated Unit Subscription Agreement, dated June 1, 2017 between the Company and the underwriters of the IPO (Filed With SEC on June 7, 2017)

Administrative Services Agreement, dated June 1, 2017, between the Company and KBL IV Sponsor LLC (Filed With SEC on June 7, 2017)

UNDERWRITINGAGREEMENT between KBLMERGER CORP. IV and LADENBURGTHALMANN & CO. INC., B.RILEY & CO. LLC, FBRCAPITAL MARKETS & CO., and I-BANKERSSECURITIES INC. Dated:[______], 2017 (Filed With SEC on May 30, 2017)

SECOND AMENDEDAND RESTATED UNIT SUBSCRIPTION AGREEMENT (Filed With SEC on May 30, 2017)

KBLMERGER CORP. IV UNITSCONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASEONE SHARE OF COMMON STOCK (Filed With SEC on May 26, 2017)

[Form of Warrant Certificate] [FACE] (Filed With SEC on May 26, 2017)

WARRANT AGREEMENT (Filed With SEC on May 26, 2017)

KBLMERGER CORP. IV INCORPORATEDUNDER THE LAWS OF DELAWARE RIGHT (Filed With SEC on May 26, 2017)

RIGHTSAGREEMENT (Filed With SEC on May 26, 2017)

[Signaturepage follows] (Filed With SEC on May 26, 2017)

INVESTMENTMANAGEMENT TRUST AGREEMENT (Filed With SEC on May 26, 2017)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on May 26, 2017)

SECONDAMENDED AND RESTATED UNIT SUBSCRIPTION AGREEMENT (Filed With SEC on May 26, 2017)

UNDERWRITINGAGREEMENT between KBLMERGER CORP. IV and LADENBURGTHALMANN & CO. INC., B.RILEY & CO. LLC and FBRCAPITAL MARKETS & CO. Dated:[______], 2017 (Filed With SEC on May 24, 2017)

[Signaturepage follows] (Filed With SEC on May 24, 2017)

AMENDEDAND RESTATED UNIT SUBSCRIPTION AGREEMENT (Filed With SEC on May 24, 2017)

UNDERWRITINGAGREEMENT between KBLMERGER CORP. IV and LADENBURGTHALMANN & CO. INC., B.RILEY & CO. LLC and FBRCAPITAL MARKETS & CO. Dated:[______], 2017 (Filed With SEC on May 9, 2017)

INVESTMENTMANAGEMENT TRUST AGREEMENT (Filed With SEC on May 9, 2017)

UNITSUBSCRIPTION AGREEMENT (Filed With SEC on May 9, 2017)

KBLMERGER CORP. IV UNITSCONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASEONE SHARE OF COMMON STOCK (Filed With SEC on April 26, 2017)

KBLMERGER CORP. IV INCORPORATEDUNDER THE LAWS OF THE STATE OF DELAWARE COMMONSTOCK (Filed With SEC on April 26, 2017)

[Form of Warrant Certificate] [FACE] (Filed With SEC on April 26, 2017)

WARRANT AGREEMENT (Filed With SEC on April 26, 2017)

PROMISSORYNOTE (Filed With SEC on April 26, 2017)

[Signaturepage follows] (Filed With SEC on April 26, 2017)

INVESTMENTMANAGEMENT TRUST AGREEMENT (Filed With SEC on April 26, 2017)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on April 26, 2017)

KBL Merger Corp. IV 150 West 56th Street New York, NY 10019 September7, 2016 (Filed With SEC on April 26, 2017)

UNITSUBSCRIPTION AGREEMENT (Filed With SEC on April 26, 2017)

AMENDED AND RESTATED UNIT SUBSCRIPTION AGREEMENT (Filed With SEC on April 26, 2017)

INDEMNITYAGREEMENT (Filed With SEC on April 26, 2017)

KBLMerger Corp. IV 527 Stanton Christiana Rd. Newark,DE 19713 (Filed With SEC on April 26, 2017)

Category

Industry

Companies

Contracts

KBL MERGER CORP. IV Contracts & Agreements